IVA Prime: automated primer design for <i>in vivo</i> assembly cloning
Resumen: Molecular cloning through in vivo assembly (IVA) is an efficient homology-based approach that can achieve complex cloning operations in a single step, bypassing the need for enzymes and reducing hands-on time and costs. However, primer design remains the most demanding task, requiring substantial expertise and a source of human error. Here, we introduce “IVA Prime,” an intuitive online tool for automated primer design for IVA cloning, which reduces the workload and avoids errors. We describe how IVA Prime generates optimized primers for all cloning operations, i.e. mutagenesis, insertions, deletions, and subcloning. IVA Prime provides an intuitive interface and robust algorithms, thus mitigating the complexities associated with primer design into a single mouse click. A set of thoroughly tested default parameters allows both inexperienced users and experts to generate ready-to-order primer sequences for a standardized cloning protocol with high success rate. We describe the method and demonstrate its efficiency and reliability with example applications. IVA Prime is freely available at https://www.ivaprime.com.
Idioma: Inglés
DOI: 10.1093/nar/gkaf386
Año: 2025
Publicado en: Nucleic Acids Research (2025), [8 pp.]
ISSN: 0305-1048

Financiación: info:eu-repo/grantAgreement/ES/MCINN/AEI/RYC2018-025720-I
Financiación: info:eu-repo/grantAgreement/ES/MICINN-AEI/PID2019-106284GA-I00
Financiación: info:eu-repo/grantAgreement/ES/MICINN-FEDER/PID2020-113359GA-I00
Financiación: info:eu-repo/grantAgreement/ES/MICINN/RYC2018-025731-I
Tipo y forma: Article (Published version)
Área (Departamento): Área Bioquímica y Biolog.Mole. (Dpto. Bioq.Biolog.Mol. Celular)
Exportado de SIDERAL (2025-10-17-14:26:47)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
articulos > articulos-por-area > bioquimica_y_biologia_molecular



 Notice créée le 2025-05-30, modifiée le 2025-10-17


Versión publicada:
 PDF
Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)